The Ritz Herald
© Drew Graham

Global COVID-19 Pandemic Disruptions Take a Toll on the Power of New Innovations to Drive Market Value


Strongest-performing sectors in Q3 benefited from spending on existing products and services, rather than new and innovative market offerings, reports The Conference Board

Published on October 01, 2020

The Conference Board Innovation α Index powered by M•CAM for the United States increased 8.8% in Q3 2020 and, at quarter’s end, is up nearly 1.7% from a year ago. The parallel Innovation α Global Index, which tracks innovative companies worldwide, increased 6.9% in Q3 and is up 3% from a year ago.

By comparison, the U.S. Russell 1000 rose 10.2% in Q3, while the global MSCI ACWI grew 7.6%. Normally, in the long run, both the U.S. and Global Innovation α Indexes outperform broad indexes like the Russell 1000 and MSCI ACWI, but this was not the case in Q3 2020—and has not been year-to-date. In the United States, the Q3 data show that innovative companies in Retail Trade, Producer Manufacturing, and Process Industries performed well, while Energy Minerals, Distribution Services, and Communications lagged other sectors. Globally, Q3’s top-performing sectors were Consumer Non-Durables, Commercial Services, Process Industries, Retail Trade, and Consumer Durables. Energy Minerals posted the worst quarterly performance in the global index.

“Some of the sectors relying heavily on incremental innovations, such as Retail Trade, Consumer Non-Durables, and Producer Manufacturing have performed quite well in Q3,” said Dana M. Peterson, Executive Vice President and Chief Economist at The Conference Board. “But their weights in the Innovation α Index aren’t as high as those for the technology-related sectors, which have shown a more mixed picture. Entering Q4, Electronic Technology, Health Technology, and Technology Services—which together make up about half of the index—are the sectors to watch. They will be key players in providing new innovations and providing a more structural response to the long-lasting effects of COVID-19—the pandemic itself, plus the disruptions set in motion through social-distancing and work-from-home policies.”

The Innovation α indexes reflect stock-market performance from one of the most fundamental sources of business growth—namely, the innovation capabilities of companies. The indexes are expected to yield long-term results that exceed market averages. Because the market performance of companies is driven by many factors in the short term, the index returns can fluctuate compared to benchmarks. The measurement of innovation outcomes requires a long-term focus. For example, the cumulative growth of $1000 invested in the Innovation α U.S. Index in January 2013 exceeds the cumulative growth of the same amount invested in the Russell 1000 index by about 10 percent.

In the U.S. index, the weights for Q4 increased the most for Technology Services, Energy Minerals, Consumer Durables, Health Services, and Producer Manufacturing. Retail Trade, Producer Manufacturing, and Process Industries showed the highest quarterly performance in the third quarter.

In the global index, Technology Services, Consumer Non-Durables, and Health Technology saw their weights for Q4 increase the most. Commercial Services, Consumer Non-Durables, Process Industries, Retail Trade, and Consumer Durables showed the highest quarterly performance in the third quarter.

“After two full quarters of global business realignment triggered by the global COVID-19 pandemic disruptions, there is compelling evidence that the power of innovation to drive market value and returns can be significantly impacted by market exogenous forces,” said David Martin, CEO of M•CAM International. “Upon closer inspection, the sectors which perform better benefited from spending on existing products and services with little innovation associated rather than new and innovative market offerings.”

Latest insights from the Innovation α Index

The Conference Board Innovation α Index powered by M•CAM was developed by M•CAM, an investment firm that analyzes intellectual property and intangible assets to support credit and equity products. It consists of two indexes that rank and identify the 100 most innovative U.S. companies in the Russell 1000 universe of companies and the 120 most innovative global companies in the MSCI World Index universe of companies.1 The selection is determined by the potential of those companies to generate substantial revenue growth through the use of proprietary technologies and innovations. The rankings result from a series of algorithms that gauge a company’s innovation standing by analyzing their patents, trademarks, and copyrights, and the value generated from them.

For the 2020 Q4 index reset, the indexes were reweighted on October 1, 2020, depending on the expected performance of their constituents.

In the U.S. index, the top five ranked companies (based on their index weights for Q4 of 2020, with their sectors shown in parentheses) are Microsoft Corporation (Technology Services), Procter & Gamble Company (Consumer Non-Durables), Halliburton Company (Industrial Services), Genworth Financial, Inc. Class A (Finance), and International Business Machines Corporation (Technology Services).

In the global index, the top five ranked companies (based on their index weights for Q4 of 2020, with their sectors shown in parentheses) are Daimler AG (Consumer Durables), Apple Inc. (Electronic Technology), Microsoft Corporation (Technology Services), adidas AG (Consumer Non-Durables), and Bayer AG (Health Technology).

“While the indexes reflect the disruptions brought on by social distancing and working from home, they also raise the potential that continuing recession and disruptions may take a toll on the development of fundamentally novel innovations in 2020,” said Ataman Ozyildirim, Senior Director of Economic Research at The Conference Board. “For example, in the diagnostics and testing arena, most of the technologies deployed in response to the challenges posed by COVID-19 are derived from relatively dated patent portfolios. According to our research partner M-CAM’s work, the coronavirus patent landscape—which includes over 5,100 patents on the virus, its detection, treatments, and vaccines—features an average patent age of over ten years.”

Finance Reporter